Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Identifying the Short-Term Neurobiological, Metabolic and Behavioural Effects of CONTRAVE as Potential Mechanisms of Weight Loss in Adults With Obesity: A Randomized, Double-Blind, Placebo-Controlled Pilot Trial

NCT06809166 is registered in ClinicalTrials.gov with The Royal's Institute of Mental Health Research as lead sponsor.

NCT NCT06809166
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06809166 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Identifying the Short-Term Neurobiological, Metabolic and Behavioural Effects of CONTRAVE as Potential Mechanisms of Weight Loss in Adults With Obesity: A Randomized, Double-Blind, Placebo-Controlled Pilot Trial
Lead sponsor
The Royal's Institute of Mental Health Research
Phase
Phase 4
Overall status
Recruiting
Start date
July 4, 2024
Completion date
July 31, 2026
Enrollment
40 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

dietary intervention, obesity, obesity/therapy, weight loss, weight management